about
Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency.Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience.Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanomaNatural-killer-cell-based treatment in haematopoietic stem-cell transplantation.Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.Natural killer cells and antifungal host response.Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocolTargeted cell entry of lentiviral vectors.Regulation of advanced therapy medicinal products in Europe and the role of academia.Myeloid and plasmacytoid dendritic cells: reference ranges in the peripheral blood of healthy children.Multimer monitoring of CMV-specific T cells in research and in clinical applications.Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia.Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing.Treatment of patients with advanced cancer with the natural killer cell line NK-92.The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy.The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).Activation of Epac stimulates integrin-dependent homing of progenitor cells.Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy.Effective treatment of leukemic cell lines with wt1 siRNA.CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.Pharmacology of intracellular cytosine-arabinoside-5'-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes.111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia.Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.Reactive oxygen species abrogate the anticarcinogenic effect of eicosapentaenoic acid in Atm-deficient mice.Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation.Age-matched dendritic cell subpopulations reference values in childhood.IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes.
P50
Q30648415-676E6488-B6D4-4082-8942-A6C720A46E85Q33257976-E0AE1CA1-3B4C-4162-B8A9-905EE9354A84Q33372029-7D4EB009-A9A6-43CD-B48F-CD8A5618B5AAQ33728489-A2DEA8A0-EFBF-4A60-BFFF-791F6F6F00C9Q34077847-F9793168-26AE-4372-8E60-3717EC3D2FF2Q34094502-EE854419-6689-4D51-9C32-383355C467ECQ34508425-7B6EF944-A918-4791-A23D-AD74F713CD6CQ34524941-8A3C4422-D628-43C8-B11C-EB9DEDB77854Q34625042-0775FB19-4DCD-4E8B-8D7B-B9CCCF92A42BQ35046126-1149068C-A8D7-4DAA-B656-8F360BF20CD6Q35203695-5E4A2381-6C11-4C4B-9510-3BE31584CAEBQ36031874-FF334025-34B9-4687-AE10-50530A94C865Q36602069-6DFADF14-4EBB-46E9-A2C9-047477EF01CEQ36642270-0C0FD407-F7C5-4E7B-87FC-8F88BCF3A993Q36757854-8D00A81A-582E-45A4-84CA-0CEFFD46BEDEQ36850695-8F82A78A-5B1E-4CE4-887F-F74DA320713DQ37589994-1AD1E271-3167-439D-BB65-5324D618E871Q38151421-CF5283D2-10FD-4C9E-85C0-6DC32BB6A0FBQ38155479-D434ED3E-FBFC-433C-B447-080C392E38A8Q38170727-A033941C-655D-46B6-9465-F8942815EECCQ38488307-99D65081-002E-40E2-A02B-32ABD7287E09Q39005853-3D131535-2E25-4D8F-AD40-5710F98A13AAQ39086459-2384170C-B109-4F4D-A42F-89A8AC3BE0D2Q39463041-03B50E48-B41A-44D5-AE98-487A06A4E2AEQ39539858-09CA1952-B968-4D64-A526-90E803B78A67Q39704843-95508B8D-C322-4678-B562-6751934FC493Q39824413-98FBC6D4-7E5C-4077-83BE-BB7F0CBDB350Q40046169-AEFFCD9C-8919-4132-BD24-60EFDA76447BQ40052359-A80BE65B-90DA-440A-BEB2-8D9768F86CD2Q40095623-406BBE50-3A03-4EE1-B0F0-9CA6C28DAC3FQ40107992-410212E1-A4A3-4F02-BB30-5B4E33672DBAQ40195918-D29CACF9-9D85-4739-98BE-B4EA6F98E92EQ40527231-4465779E-0D8E-43D8-BE5A-8111BBEB65C2Q42710633-A20FAF1F-C5F4-4A27-91CE-61BF22A17C05Q42863043-E4E49F9D-7F5A-4F50-90AA-4AB463C6F714Q43006944-7DDEABE8-CBA7-46B3-9087-443CC3B09020Q43486301-961E1BDF-A366-44A8-ACF0-88E0B678BD88Q43672837-6B824328-52E6-4023-B2AF-0799F7FB5AFAQ44365247-1BB0EBA8-C7B3-498B-97C4-796457CD100AQ44495832-9C792102-D0DE-4713-B75D-A21DBF059061
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
taighdeoir
@ga
wetenschapper
@nl
հետազոտող
@hy
name
Ulrike Koehl
@ast
Ulrike Koehl
@en
Ulrike Koehl
@es
Ulrike Koehl
@nl
Ulrike Koehl
@sl
type
label
Ulrike Koehl
@ast
Ulrike Koehl
@en
Ulrike Koehl
@es
Ulrike Koehl
@nl
Ulrike Koehl
@sl
prefLabel
Ulrike Koehl
@ast
Ulrike Koehl
@en
Ulrike Koehl
@es
Ulrike Koehl
@nl
Ulrike Koehl
@sl
P214
P227
P106
P21
P213
0000 0000 6229 1406
P214
P227
P31
P496
0000-0002-8159-9160
P569
1963-01-01T00:00:00Z
P735
P7859
viaf-89868714